Ra Capital Management, L.P. Humacyte, Inc. Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
A detailed history of Ra Capital Management, L.P. transactions in Humacyte, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,312,356 shares of HUMA stock, worth $6.19 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,312,356Holding current value
$6.19 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
180Shares Held
59.8MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$13.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$12.3 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$7.98 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$7.53 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$7.39 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $193M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...